Proteon Therapeutics, Inc. (PRTO)

[Jt0082]

for me totally not interested in vona for PAD! But hey guess it could be a bonus.

The market for radio cephalic AVFs's globally is big. If patency-2 is successful I would hope that they spend most of their time building penetration in radio cephalic AVF's primarily and then just licencing vona outside of USA.

what do you value co at if hits fredman? AND

what % level of improvement in the curves are you looking at for it to be considered clinically meaningful?